Labshake search
Citations for R&D Systems :
351 - 400 of 2664 citations for Recombinant Human FABP6 Protein since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Systems Biology 2021Quote: ... 200 ng/mL of recombinant human FGF5 (R&D Systems, #237-F5), 100 ng/mL of recombinant mouse PDGFA (Novus ...
-
bioRxiv - Genetics 2020Quote: ... and 100 ng/ml recombinant human SCF (R&D systems #255-SC) (referred to as X-VIVO complete medium) ...
-
bioRxiv - Cell Biology 2020Quote: ... Recombinant human TGF-β1 (#240-B) was purchased from R&D systems.
-
bioRxiv - Cell Biology 2020Quote: ... Recombinant human TGF-β1 (#240-B) was from R&D Systems (UK) and used at a final concentration of 0.5 ng/ml ...
-
bioRxiv - Immunology 2020Quote: ... Pen-Strep and human recombinant interleukin-2 (210U/mL, R&D systems). For activation ...
-
bioRxiv - Cell Biology 2022Quote: ... 10 ng/mL human recombinant activin B (R&D Systems, Minneapolis, MN), 0.1 nmol/L exendin-4 (Sigma) ...
-
bioRxiv - Cancer Biology 2022Quote: ... Serum-starved cells were stimulated with human recombinant TGFβ1 (R&D Systems) for 16h.
-
bioRxiv - Bioengineering 2024Quote: ... supplemented with 10 ng/mL recombinant human IL-7 (R&D Systems). For culture ...
-
bioRxiv - Cell Biology 2024Quote: ... and recombinant human FGF basic146 aa (10 ng/ml, R&D Systems) for another 2 weeks as previously described37.
-
Phospholipase C β4 promotes RANKL-dependent osteoclastogenesis by interacting with MKK3 and p38 MAPKbioRxiv - Cell Biology 2024Quote: Recombinant human RANKL was purchased from R&D Systems (Minneapolis, MN, USA), and M-CSF was obtained from PeproTech (Rocky Hill ...
-
bioRxiv - Immunology 2024Quote: ... recombinant human IL-2 (R&D systems, cat # 202-IL-010/CF), and SIINFEKL peptide (0.5ug ...
-
bioRxiv - Molecular Biology 2023Quote: ... human recombinant basic fibroblast growth factor (bFGF; R&D Systems Europe, Ltd.), human leukemia inhibitory factor (Millipore ...
-
bioRxiv - Cell Biology 2023Quote: ... and 25ng/mL recombinant human BMP4 (Cat. 314-BP, R&D Systems), at ∼0.7ml of medium per cm2 of cultured area ...
-
bioRxiv - Developmental Biology 2023Quote: ... 50 ng/ml recombinant human epidermal growth factor (rhEGF; R&D Systems), 2 µM CHIR99021 (Tocris ...
-
bioRxiv - Cancer Biology 2023Quote: ... Th2 condition: Recombinant human IL-4 (10 ng/ml, R&D Systems), IL-5 (10 ng/ml ...
-
bioRxiv - Bioengineering 2023Quote: ... and 10 ng mL− 1 FGF-10 (human recombinant) (R&D Systems). The cells were then treated with RPMI medium GlutaMax™ Supplement containing 2% (v/v ...
-
bioRxiv - Immunology 2023Quote: ... and/or 1.14 μg/mL human recombinant ICAM-1 (R&D system) in DPBS for 1 h at 37°C and blocked with 1.5% (v/v ...
-
bioRxiv - Immunology 2023Quote: ... recombinant human CCL2 (100 ng/ml, 279-MC-010; R&D Systems) was added to the cells immediately before loading them into the flow chamber and the CCL2 concentration was maintained during the initial 4 min of the assay.
-
bioRxiv - Genomics 2023Quote: ... followed by recombinant human BMP-4 (5 ng/mL; R&D Systems) and CHIR 99021 (1 nM ...
-
bioRxiv - Immunology 2023Quote: ... recombinant human CDH11-Fc chimera (CDH11Fc, R&D Systems; Cat# 1970-CA) or H1M1 antibody (prepared from hybridoma PTA-9699 (ATCC ...
-
Single-cell profiling and zebrafish avatars reveal LGALS1 as immunomodulating target in glioblastomabioRxiv - Cancer Biology 2023Quote: ... supplemented with 50 ng/ml GM-CSF (Recombinant human, R&D Systems), 10% heat-inactivated FBS (Gibco) ...
-
bioRxiv - Molecular Biology 2023Quote: ... 9 ng/ml Recombinant Human/Mouse/rat Activin A (R&D Systems) and 5 ng/ml human FGF-2 (Miltenyi Biotec) ...
-
bioRxiv - Biochemistry 2023Quote: ... 50 μM of human recombinant untagged ubiquitin (R&D SYSTEMS, U-100H) and specific human recombinant DUBs were added at the same concentration as for the proteomic experiments (800 nM) ...
-
bioRxiv - Cell Biology 2023Quote: ... and recombinant human FGF basic146 aa (10 ng/ml, R&D Systems) for another 2 weeks as previously described(60).
-
bioRxiv - Immunology 2023Quote: ... and recombinant human IL-2 (rhIL2,50 U/mL; R&D Systems/CellGenix)) with or without 1% penicillin/streptomycin/l-glutamine (Invitrogen) ...
-
bioRxiv - Immunology 2024Quote: ... and 100 ng/ml human recombinant APRIL/TNFSF-13 (R&D systems). Human healthy donor peripheral blood mononuclear cells (PBMC ...
-
bioRxiv - Immunology 2024Quote: ... recombinant human TNFα (10 ng/ml) (10291-TA-020, R&D Systems), poly I:C (1µg / ml ...
-
bioRxiv - Molecular Biology 2024Quote: ... 50 ng/ml recombinant human epidermal growth factor (rhEGF; R&D Systems), 2 µM CHIR99021 (Tocris ...
-
bioRxiv - Cancer Biology 2024Quote: ... Recombinant human IFN-γ was purchased from R&D Systems (Minneapolis, MN).
-
bioRxiv - Immunology 2021Quote: The expression of NKG2D ligands in tumor cell lines was assessed using Recombinant Human NKG2D Fc Chimera Protein (R&D systems, Abingdon, UK). 105 tumor cells were incubated either with 0.5 μg of NKG2D Fc recombinant protein or IgG1-Fc during 30 min ...
-
bioRxiv - Systems Biology 2023Quote: Where indicated the cells were stimulated with the final concentration of 10 ng/ml of recombinant human TNF-α protein (R&D Systems) or 100 ng/ml of recombinant human interleukin 1 beta (IL-1β ...
-
bioRxiv - Physiology 2023Quote: ... ciCMVEC were placed in serum-free media 1h before treatment with 10 ng/ml of Recombinant Human TNF-α Protein (210-TA-005; R&D systems) or vehicle (PBS ...
-
bioRxiv - Bioengineering 2024Quote: ... IDUA activity was assessed using 4-methylumberlliferyl-alpha-L-iduronide (Glycosynth, Cheshire, England) and recombinant human alpha-L-iduronidase protein (R&D systems, Minneapolis) following manufacturer’s instructions.
-
bioRxiv - Immunology 2023Quote: ... IL-2 complex was made with 1.5μg of recombinant human IL-2 (NIH) and 7.5μg of anti-human IL-2 (R&D Systems) per injection in 100μL of sterile PBS ...
-
bioRxiv - Physiology 2021Quote: ... recombinant mouse BMP4 Protein (R&D Systems, 5020-BP-010) [diluted in 0.1% BSA ...
-
bioRxiv - Cancer Biology 2022Quote: ... recombinant mouse PD-1-Fc chimeric protein (R&D Systems) or human IgG1 control (R&D Systems) ...
-
bioRxiv - Microbiology 2023Quote: ... recombinant mouse Gas6 protein (R&D Systems, cat# 986-GS) (used in administration experiments in mice) ...
-
bioRxiv - Genetics 2023Quote: Recombinant Mouse IFNγ Protein (R&D Systems, 485-MI-100) was added to the NPC medium at a concentration of 10 ng/ml from day 0-5 ...
-
bioRxiv - Genetics 2023Quote: Recombinant Mouse IFNγ Protein (R&D Systems, 485-MI-100) was added to the iPSC medium at a concentration of 10 ng/ml from day 0-5 ...
-
bioRxiv - Immunology 2023Quote: ... recombinant mouse Fc-chimera proteins CD6 (rCD6, R&D Systems) and/or ICAM-1 (rICAM1 ...
-
bioRxiv - Developmental Biology 2019Quote: ... Both wild type and Adgrg6 KO ATDC5 cells were treated with 100ng/ml recombinant human IL-6 protein (rIL-6) (R&D System, 206-IL) for 2 hours before protein extraction.
-
bioRxiv - Immunology 2021Quote: ... and either 7µg of Recombinant PD-L1/B7-H1 Fc Chimera Protein (mouse: R&D System 1019-B7; human: R&D System 156-B7) (indicated as anti-CD3/28-PDL1-beads ...
-
bioRxiv - Immunology 2021Quote: ... and either 7µg of Recombinant PD-L1/B7-H1 Fc Chimera Protein (mouse: R&D System 1019-B7; human: R&D System 156-B7) (indicated as anti-CD3/28-PDL1-beads ...
-
bioRxiv - Pharmacology and Toxicology 2021Quote: ... Human ACE2 Biotinylated Antibody (Cat # BAF933) and Recombinant Spike S1 RBD protein (Cat # NBP2-90982) were obtained from R&D Systems (Minneapolis, MN, 55413) and NOVUS Biologicals (Centennial ...
-
bioRxiv - Cancer Biology 2022Quote: ... miniloci in an endogenous IgH and Igκ knockout background (19,20) were immunized with recombinant human LAG-3–Fc protein (hLAG-3–hFc) (R&D Systems, Minneapolis, MN, USA), consisting of the extracellular domain of LAG-3 (Leu23-Leu450 ...
-
bioRxiv - Cancer Biology 2022Quote: ... +/-1 µg/mL anti-CD28 (CD28.2) antibody (eBioscience/Thermo 16-0289-81) or recombinant human CD58-Fc chimera protein (R&D Systems 10068-CD-050) at 37 ºC for 2 hours ...
-
bioRxiv - Neuroscience 2022Quote: ... a mix of 10 μg/mL Laminin and 5 μg/mL of each SLRP protein (recombinant human CHAD (R&D Systems Cat#8218-CH), FMOD (R&D Systems Cat#9840-FM) ...
-
bioRxiv - Bioengineering 2024Quote: ... Different concentrations of endogenous Cyr61 (0-200 ng/ml; Recombinant Human Cyr61/CCN1 Fc Chimera Protein, carrier-free; catalog no.: 4055-CR; R&D Systems, Minneapolis, MN) and TGFβ (0 or 10 ng/ml ...
-
bioRxiv - Bioengineering 2024Quote: ... 0.1% v/v FBS with or without 100 ng/ml Cyr61 (Recombinant Human Cyr61/CCN1 Fc Chimera Protein, carrier-free; catalog no.: 4055-CR; R&D Systems, Minneapolis, MN). Medium change was performed at day 3 and images were taken at 3 and 5 days using a Keyence BZ-X800 Fluorescence Microscope (Keyence ...
-
bioRxiv - Bioengineering 2024Quote: A total of 1 μg Cyr61 (Recombinant Human Cyr61/CCN1 Fc Chimera Protein, carrier-free; catalog no.: 4055-CR; R&D Systems, Minneapolis, MN) was dissolved in GelMA/fibrin hydrogel containing thrombin and transferred into a cylinder-shaped mold with a liquid capacity of 8.6 μl and 1 mm diameter with 1 mm thickness ...